Literature DB >> 28166861

Effect of dignity therapy on end-of-life psychological distress in terminally ill Portuguese patients: A randomized controlled trial.

Miguel Julião1, Fátima Oliveira2, Baltazar Nunes3, António Vaz Carneiro4, António Barbosa5.   

Abstract

OBJECTIVE: Dignity therapy (DT) is a brief form of psychotherapy developed for patients living with a life-limiting illness that has demonstrated efficacy in treating several dimensions of end-of-life psychological distress. Our aim was to determine the influence of DT on demoralization syndrome (DS), the desire for death (DfD), and a sense of dignity (SoD) in terminally ill inpatients experiencing a high level of distress in a palliative care unit.
METHOD: A nonblinded phase II randomized controlled trial was conducted with 80 patients who were randomly assigned to one of two groups: the intervention group (DT + standard palliative care [SPC]) or the control group (SPC alone). The main outcomes were DS, DfD, and SoD, as measured according to DS criteria, the Desire for Death Rating Scale, and the Patient Dignity Inventory (PDI), respectively. All scales were assessed at baseline (day 1) and at day 4 of follow-up. This study is registered with http://www.controlled-trials.com/ISRCTN34354086.
RESULTS: Of the 80 participants, 41 were randomized to DT and 39 to SPC. Baseline characteristics were similar between the two groups. DT was associated with a significant decrease in DS compared with SPC (DT DS prevalence = 12.1%; SPC DS prevalence = 60.0%; p < 0.001). Similarly, DT was associated with a significant decrease in DfD prevalence (DT DfD prevalence = 0%; SPC DfD prevalence = 14.3%; p = 0.054). Compared with participants allocated to the control group, those who received DT showed a statistically significant reduction in 19 of 25 PDI items. SIGNIFICANCE OF
RESULTS: Dignity therapy had a beneficial effect on the psychological distress encountered by patients near the end of life. Our research suggests that DT is an important psychotherapeutic approach that should be included in clinical care programs, and it could help more patients to cope with their end-of-life experiences.

Entities:  

Keywords:  Dignity therapy; End-of-life psychological distress; Palliative care; Randomized controlled trial

Mesh:

Year:  2017        PMID: 28166861     DOI: 10.1017/S1478951516001140

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  6 in total

1.  Effects and satisfaction of dignity therapy among patients with hematologic neoplasms in the Chinese cultural context: a randomized controlled trial.

Authors:  Jingyi Chen; Jie Yan; Chunfeng Wang; Ying Wang; Yong Wu; Rong Hu
Journal:  Support Care Cancer       Date:  2021-05-17       Impact factor: 3.603

Review 2.  Palliative Care Models for Cancer Patients: Learning for Planning in Nursing (Review).

Authors:  Hadi Hassankhani; Azad Rahmani; Fariba Taleghani; Zohreh Sanaat; Javad Dehghannezhad
Journal:  J Cancer Educ       Date:  2020-02       Impact factor: 2.037

3.  The desire for death in Portuguese home-care palliative patients: Retrospective analysis of the prevalence and associated factors.

Authors:  Miguel Julião; Maria Ana Sobral; Paula Calçada; Bárbara Antunes; Daniela Runa; Catarina Samorinha; Harvey Max Chochinov; William Breitbart
Journal:  Palliat Support Care       Date:  2021-08

4.  Randomized control trial of advanced cancer patients at a private hospital in Kenya and the impact of dignity therapy on quality of life.

Authors:  John Weru; Miriam Gatehi; Alice Musibi
Journal:  BMC Palliat Care       Date:  2020-07-23       Impact factor: 3.234

Review 5.  The Present State of Existential Interventions Within Palliative Care.

Authors:  Takeshi Terao; Moriaki Satoh
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

6.  Feasibility, acceptability and adaption of dignity therapy: a mixed methods study achieving 360° feedback.

Authors:  Sandra Stephanie Mai; Swantje Goebel; Elisabeth Jentschke; Birgitt van Oorschot; Karl-Heinz Renner; Martin Weber
Journal:  BMC Palliat Care       Date:  2018-05-10       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.